by Molly Chiu, Baylor College of Medicine Chronic meyloid leukemia under a microscope. Credit: Baylor College of Medicine Researchers at Baylor College of Medicine and collaborating institutions have engineered immune cells to control two major life-threatening complications, namely graft-vs-host disease (GvHD) and cancer relapse, which typically emerge after treating leukemia with allogeneic hematopoietic stem cell...
